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Age-related macular degeneration (AMD) is characterized by retinal pigment epithelial (RPE) cell dysfunction beginning at
early stages of the disease. The lack of an appropriate in vitro model is a major limitation in understanding the mechanisms
leading to the occurrence of AMD. This study compared human-induced pluripotent stem cell- (hiPSC-) RPE cells derived
from atrophic AMD patients (77 y/o ± 7) to hiPSC-RPE cells derived from healthy elderly individuals with no drusen or
pigmentary alteration (62:5 y/o ± 17:5). Control and AMD hiPSC-RPE cell lines were characterized by immunofluorescence,
flow cytometry, and electronic microscopy. The toxicity level of iron after Fe-NTA treatment was evaluated by an MTT test
and by the detection of dichloro-dihydro-fluorescein diacetate. Twelve hiPSC-RPE cell lines (6 AMD and 6 controls) were
used for the experiment. Under basal conditions, all hiPSC-RPE cells expressed a phenotypic profile of senescent cells with
rounded mitochondria at passage 2. However, the treatment with Fe-NTA induced higher reactive oxygen species production
and cell death in hiPSC-RPE AMD cells than in hiPSC-RPE Control cells. Interestingly, functional analysis showed
differences in lysosomal activity between the two populations. Indeed, Cathepsin B activity was higher in hiPSC-RPE AMD
cells compared to hiPSC-RPE Control cells in basal condition and link to a pH more acidic in this cell population.
Moreover, oxidative stress exposure leads to an increase of Cathepsin D immature form levels in both populations, but in a
higher proportion in hiPSC-RPE AMD cells. These findings could demonstrate that hiPSC-RPE AMD cells have a typical
disease phenotype compared to hiPSC-RPE Control cells.
1. Introduction
Age-related macular degeneration (AMD), a multifactorial
disease caused by age and genetic and environmental factors
[1], is the first cause of blindness in the elderly population in
developed countries [2]. The disease is characterized by the
accumulation of drusen, extracellular deposits of proteins
and lipids and by progressive cellular degeneration of retinal
pigment epithelial (RPE) cells located in the macular area [3].
The exudative form of AMD is characterized by choroidal
neovascularization, and the atrophic form, also called dry
form, is characterized by progressive RPE cell degeneration
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finally associated with photoreceptor loss [3]. Understand-
ing the molecular mechanisms involved in AMD has been
challenging due to the lack of an appropriate in vitro
model [4].
Induced pluripotent stem cells (iPSC) derived from
somatic cell lines are indistinguishable from embryonic stem
(ES) cells in terms of morphology, proliferation, gene expres-
sion, and teratoma formation [5]. They also have the ability
to be expanded indefinitely in culture and to differentiate into
multiple lineages [6]. Many improvements in cell reprogram-
ming and differentiation have yielded specific populations of
diversified kinds of cells such as retinal cells [7, 8]. Since the
last decade, the generation of RPE cells from hiPSC has been
investigated to model the ocular disorders associated with
dysfunction of RPE cells [9]. While the ARPE-19, an immor-
talized human RPE cell line, is currently used as an in vitro
model for retinal diseases, many studies have reported major
differences (pigmentation, RPE cell marker expression,
transepithelial resistance, protein secretion level, and so on)
between ARPE-19 cells and human fetal or adult hRPE cells
and iPSC-RPE cells [10–12].
RPE cells are highly polarized monolayer cells character-
ized by pigmentation, octagonal morphology, and tight junc-
tion. These cells play a key role in many functions such as
retinal blood barrier, nutriment and water input, light
absorption and phagocytosis of photoreceptor outer segment
(POS), and retinol recycling [13, 14]. Many studies have
observed morphological and functional changes in RPE cells
during the aging process (mitochondrial damage, lysosomal
dysregulation, accumulation of lipofuscin, and so on) sug-
gesting that these cells play a role in the pathogenesis of
AMD [15–17]. Chronic oxidative stress is likely an important
contributing environmental risk factor to the development of
AMD. Previous in vitro studies have shown that exposure to
drugs inducing oxidative stress leads to both functional and
morphological RPE alterations [18, 19]. Indeed, accumula-
tion of iron, an essential element in many metabolic pro-
cesses that accumulates with normal aging [16], may be
involved in the pathogenesis of AMD as a source of free rad-
icals contributing to tissue damage through lipidic mem-
brane alterations and protein modifications [20]. Iron is
responsible for reactive oxygen species (ROS) production
by Fenton reaction, and it has been observed that iron accu-
mulates more within the macular area and RPE cells in peo-
ple affected by atrophic AMD [21]. One consequence of RPE
cell oxidative stress exposure is the rapid formation and accu-
mulation of nondegradable pigment lipofuscin within the
lysosomal compartment hampering phagocytosis and even-
tually promoting cell death [22]. Dysregulation of autophagy,
a lysosome-mediated degradation process for nonessential or
damaged cellular constituents, seems to have a role in AMD
development [23].
This study is aimed at comparing lysosomal function of
hiPSC-RPE cells derived from healthy individuals to those
derived from patients affected with atrophic AMD under oxi-
dative stress conditions induced by iron intracellular accu-
mulation. Indeed, it has been shown recently that iPSC-
RPE cells derived from both skin and RPE cells of AMD
donors exhibit AMD-like phenotypes including susceptibil-
ity to oxidative stress, increased levels of ROS, and lower
mitochondrial activity [4, 24]. In our study, we demonstrated
that hiPSC-RPE cells derived from patients affected by atro-
phic AMD expressed a specific disease phenotype compared
to iPSC-RPE cells derived from healthy individuals. We con-
firmed that hiPSC-RPE cells derived from AMD patients
could be a useful tool to study pathological mechanisms lead-
ing to the development of AMD or to evaluate potential ther-
apeutic molecules.
2. Materials and Methods
2.1. Patients. Peripheral venous blood samples from individ-
uals without retinal disease and patients affected by atrophic
AMD were obtained after obtaining informed consent and in
accordance with the Committee for Protection of Persons
(no. 20152528) and with the tenets of the Declaration of
Helsinki. Fibroblast cell lines were obtained from Coriell
Institute for Medical Research (New Jersey, USA).
Retinal phenotype of atrophic AMD patients was
assessed by multimodal imaging including color fundus pho-
tographs and OCT (Optical Coherence Tomography) scans
(Spectralis®, Heidelberg Engineering, Germany).
2.2. hiPSC Generation from Blood Cells and Fibroblasts.
We followed the methods of Voisin et al. [12]. Peripheral
blood mononuclear cells (PBMC) were isolated from the
blood by Ficoll. They were maintained in StemSPAN
media (StemCell, Vancouver, Canada) supplemented with
50 ng/mL SCF (R&D, Lille, France), 2U/mL EPO (R&D),
10μg/mL FGF2 (Peprotech, Neuilly-sur-Seine, France),
500 U/mL, 1mM dexamethasone (Sigma), 40μg/mL IGF-
1 (Miltenyi, Bergisch Gladbach, Germany), 10μg/mL IL-3
(Miltenyi), and 50ng/mL ascorbic acid (Sigma). Cells were
nucleofected with Yamanaka factors OCT3/4, Sox2, KLF4,
and L-Myc (Addgene, Cambridge, MA, USA: pCXLE-
hOCT3/4-shp53-F, pCXLE-hUL, and pCXLE-hSK). At day
4 after nucleofection, cells were plated onto feeders (MTI-
GlobalStem, Gaithersburg, MD, USA). During 10 days, cells
were cultured into DMEM/F12 media supplemented with
10% KSR (Invitrogen, Carlsbad, CA, USA), 10μg/mL
FGF2, 2μM SB431542 (R&D), 0.5μM PD0325901 (Eurome-
dex, Souffelweyersheim, France), 2μM thiazovivin (R&D),
3μMCHIR99021 (Bertin Pharma, Montigny-le-Bretonneux,
France), 0.5mM VPA (Sigma), and 0.25mM NaB (Sigma).
Fibroblast cell lines were nucleofected with Yamanaka
factors using the same protocol as described for PBMC. At
day 4 after nucleofection, DMEM/F12 media were supple-
mented with 10% KSR, 10μg/mL FGF2, 2μM SB431542,
0.5μM PD0325901, and 0.5mM VPA.
At day 10 postreprogramming, VPA and NaB were
removed from the culture medium. At day 15 postrepro-
gramming, SB461542, PD0325901, CHIR99021, and thiazo-
vivin were removed from the culture medium. hiPSC
colonies appeared after around 15-20 days of culture and
were collected about 2-3 weeks postnucleofection. The cul-
ture medium (DMEM F/12+20% KSR+10μg/mL FGF2)
was changed every day.
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2.3. Differentiation of hiPSC into RPE. hiPSC were differenti-
ated into RPE cells by switching the culture medium to
DMEM High Glucose (Invitrogen) supplemented with 20%
KSR without FGF2 as previously described [7, 12]. Pigmen-
ted areas with typical RPE appearance usually appeared three
weeks after initiation of differentiation. Specific selection of
RPE cells was obtained after manual transfer of the pigmen-
ted colonies into new plates (P0). hiPSC-RPE cells were cul-
tured with DMEM High Glucose supplemented with 4%
KSR. The medium was changed twice a week. hiPSC-RPE
cells were passaged every 3 weeks up to two passages.
2.4. hiPSC and RPE Characterization. As previously
described [12], cells were stained with pluripotency and
RPE-specific cell markers for immunostaining and flow
cytometry analysis. Briefly, hiPSC were fixed with cold 4%
paraformaldehyde for 20min and washed twice with
phosphate-buffered saline (PBS). Nonspecific binding sites
and permeabilization were performed using a blocking solu-
tion containing PBS, 0.1% Triton X-100 (Sigma), 5% Goat
Serum, and 5% Horse Serum (Sigma) for 1 hour. Cells were
then incubated overnight at 4°C with the following primary
antibodies diluted in blocking solution: OCT-4 (1/200,
Abcam, Cambridge, MA, USA), NANOG (1/200, Abcam),
ZO-1 (1/100, Thermo Fisher, Wathman, MA, USA),
Bestrophin-1 (1/100, Novus Biological, Littleton, CO, USA),
Pax6 (1/75, Abcam), and Tyrosinase (1/100, Abcam). Cells
were washed twice in PBS, followed by staining with the sec-
ondary antibodies (for OCT-4, Bestrophin-1, and Tyrosi-
nase: Donkey Anti-Rabbit IgG H&L Alexa Fluor 555
(Abcam); for NANOG, Pax6, and ZO-1: Goat Anti-Mouse
IgG H&L Alexa Fluor 488 (Abcam)). Nuclei were stained
with DAPI (Invitrogen), and slides were mounted in mowiol
(Sigma). Cells were observed with a Zeiss microscope and
counted using ZEN software (Iéna, Germany).
For FACS analysis, hiPSC were dissociated using accutase
(Thermo Fisher) for 5min at room temperature, then washed
with DMEM/F12 media with 10% KSR and incubated with
the following primary conjugated antibodies: anti TRA-1-
81-AlexaFluor 647 (1/25; BD Biosciences, Franklin Lakes,
NJ, USA) and anti SSEA3-AlexaFluor 488 (1/10; BD Biosci-
ences) for 30min at 4°C in the dark. Stained cells were
washed twice in PBS supplemented with 2% SVF. Cells were
analyzed on FACSVerse (BD Biosciences) with 100,000
events acquired for each sample. Data were analyzed with
FlowJo® software (Ashland, OR, USA).
For phosphatase alkaline activity, hiPSC were fixed with
95% ethanol and incubated 10 minutes with the Sigma Fast
BCIP/NBT kit (Sigma) following themanufacturer’s instructions.
2.5. Transmission Electron Microscopy. hiPSC-RPE cells were
fixed for 1 h with 2.5% glutaraldehyde in 1M phosphate-
buffered saline (pH7.1). After PBS washes, cells were post-
fixed for 45min in 1% osmium tetroxide in phosphate buffer.
Dehydration was carried out using successive incubations of
increasing ethanol concentrations (from 50% to 100%).
Throughout this experimental protocol, each incubation
was centrifuged at 1000 rpm for 5min at room temperature.
Cell pellets were included in Epon resin and after 24 h of
polymerization; 70 nm sections were revalidated using an
ultracut UC6 of LEICA. Uranyl acetate (2% in 70% ethanol)
and lead citrate were used as contrasting agents. Pictures were
obtained on a JEOL1010 electronmicroscope at 80 kVwith an
Olympus digital camera (Quemesa) using Item software.
2.6. Measure of Senescence by β-Gal Activity. hiPSC-RPE cells
were seeded in 24-well plates and allowed to mature for up to
3 weeks following final passage (P2). Cells at confluency
showing typical cobblestone morphology and displaying pig-
mentation were stained with SA-β-gal assay detection kit
(Abcam) according to the manufacturer’s instructions. The
percentage of SA-β-gal positive cells was calculated by count-
ing the number of labeled cells manually with ZEN software.
2.7. Iron Treatment and Induction of Oxidative Stress. hiPSC-
RPE cells (3 weeks after P2) were treated for 24 hours with
Fe-NTA at final concentrations of 5 to 20mM. Cells were
washed with PBS and incubated with 1mL of fresh culture
medium supplemented by 10μg/mL of DCFH-DA [25]
(Sigma) for 1 hour at 37°C. Oxidation of dichloro-dihydro-
fluorescein (DCFH) by ROS to 2′,7′-dichlorofluorescein
DCF led to the formation of a green fluorescent oxidation
product [25]. The cells were washed with PBS and main-
tained in 1mL of PBS-2% SVF culture medium. Fluorescence
was measured with a microplate reader (Berthold Technolo-
gies, Bad Wildbad, Germany; excitation 488 nm, emission
535 nm), and the intensity values were calculated with
Mithras software (Berthold Technologies).
2.8. MTT Assay.MTT assay (Sigma) was used to reflect cellu-
lar viability as previously described [26]. Briefly, after 24
hours of Fe-NTA exposure, the medium was replaced with
0.5mg/mLMTT. Following 3h and 30 minutes of incubation
at 37°C, cells were lysed with DMSO [27]. Absorbance was
then read at 540nm and 620nm (background) with a micro-
plate reader (Tecan, Männedorf, Suisse) and analyzed with
Magellan software (Tecan).
2.9. Flow Cytometry Analysis. The change in mitochondrial
transmembrane potential induced by Fe-NTA treatment
in iPSC-RPE cell lines was observed using the appropriate
fluorescent probe JC-1 (Thermo Fisher) [28]. The
potential-sensitive color shift of JC-1 is caused by changes
in the concentration of red fluorescent JC-1 aggregates.
Mitochondrial depolarization is indicated by a decrease in
aggregated JC-1 that emits a red fluorescence. Briefly, cells
were labeled with 2μmol/L of JC-1 for 25min at 37°C,
washed with PBS, and analyzed on the flow cytometer
FACSVerse (BD Biosciences) using 488 nm excitation with
530 and 585 nm band pass emission filters. The red/green
fluorescence intensity ratio quantified mitochondrial poten-
tial using FlowJo® software (Ashland, OR).
Lysosomal activity was observed using the lysosomal
activity assay kit (Clinisciences, France). After Fe-NTA
treatment, cells were incubated for 1 h with 15μL of self-
quenched substrate in 1mL of media supplemented with
0.5% of FBS. Cells were washed twice with ice-cold 1X
assay buffer and analyzed on the flow cytometer FACS-
Verse (BD Biosciences).
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2.10. Western Blot. hiPSC-RPE cells were lysed in the extrac-
tion buffer containing 50mM Tris-HCl pH7.5, 150mM
NaCl, 1mM EDTA, 10% NP40, 0.1% de SDS, 12mM sodium
desoxycholate, 1mMNa3VO4, 1mMNaF, and 2mM PMSF.
Cells were sonicated for 10 seconds before protein concentra-
tion determination by Bradford colorimetric assay. Forty
micrograms of proteins was separated on SDS-PAGE and
electrotransferred onto polyvinylidene difluoride mem-
branes. The membrane was blocked in 5% nonfat milk and
0.1% Tween 20 in PBS and was then incubated with primary
antibodies (Transferrin, Santa Cruz; β-actin, Invitrogen;
Cathepsin D, GeneTex) at 4°C overnight. The membrane
was rinsed with 0.1% Tween 20 in PBS and incubated with
secondary antibody for 1 hour. Blots were developed by
enhanced chemiluminescence (ECL). Relative band density
was determined with ImageJ software (developed by Wayne
Rasband, National Institutes of Health, Bethesda, MD; avail-
able at http://rsb.info.nih.gov/ij/index.html). β-Actin was
used as a loading and quality control.
2.11. Measure of Cathepsin B Activity. To analyze the activity
of Cathepsin B (Cat B), we used SensoLyte 520 Cathepsin B
assay Kit (AnaSpec) according to the kit instructions. Briefly,
treated hiPSC RPE cells were incubated 10 minutes at RT
with the assay buffer before adding 50μL of 1X Cat B sub-
strate solution into each well. The fluorescence signal
(Ex/Em: 490nm/535 nm) was measured after 30 minutes of
enzymatic reaction using a microplate reader and analyzed
with Magellan software. Positive (Cat B enzyme) and nega-
tive controls (assay buffer) were used to ensure the quality
of the test.
2.12. Acridine Orange Staining for Investigation of Lysosomal
Acidification. Lysosomal stability was assessed by the AO-
relocation method. AO exhibits red fluorescence at high con-
centrations (in intact lysosomes), but green fluorescence at
low concentrations (when lysosomal contents diffuse into
the cytosol) [29]. hiPSC-RPE cells were loaded with 1μM
acridine orange (AO, Thermo Fisher) for 15min at 37°C
and were harvested with PBS (pH7.4). Quantitative compar-
isons were performed in 96-well plates, and the fluorescence
(excitation/emission.485/535 nm for monomer, 450/665 nm
for dimer) was measured with a microplate reader and ana-
lyzed with Magellan software. The ratio of fluorescence of
the dimer and oligomer to that of the monomer was calcu-
lated. For microscopy observations, samples were observed
under a fluorescence microscopy. Lysosomal stability was
assessed by red AO-fluorescence, using ZEN software.
3. Results
3.1. Patients. Individuals included in the control group (6
patients, 62:8 ± 16 y/o) were patients with normal fundus
examination, with no drusen or pigmentary alteration and
no familial history of AMD (Figures 1(a) and 1(d)).
The diagnosis of atrophic AMD (6 patients, 77:5 ± 7 y/o)
was performed on fundus examination, color photographs,
and SD-OCT scans. Patients with any history of exudative
AMD or mixt form (atrophic AMD in one eye and exudative
AMD in the fellow eye or both forms in the same eye) of the
disease were excluded. These patients presented typical accu-
mulation of drusen, RPE, and photoreceptor atrophy and
choroidal thinning (Figures 1(b) and 1(c)).
3.2. Derivation and Characterization of hiPSC-RPE Cells from
Erythroblasts and from Fibroblasts. hiPSC showed typical
hES-like morphology and had alkaline phosphatase activity
(Figure 2(a)). Flow cytometry revealed the expression of
two key pluripotency markers SSEA-3 and TRA-1-81
(Figure 2(b)). This result was confirmed by immunofluores-
cence labeling of hiPSC colonies with the expression of two
other characteristics markers of stem cells OCT4 and
NANOG (Figure 2(c)).
hiPSC-RPE cells formed a confluent monolayer display-
ing the classical cobblestone morphology (Figure 2(d)).
Transmission electronic microscopy showed typical matura-
tion patterns of hiPSC-RPE cells, including microvilli, mela-
nosomes, and mitochondria (Figure 2(e)). Flow cytometry
analysis of hiPSC-RPE cells demonstrated the presence of
TYRP1 and α-cytokeratin and the absence of Lin28, another
typical pluripotency marker (Figure 2(f)). This result was
confirmed by immunostaining with the expression of RPE-
specific marker protein Bestrophin-1 (BEST-1), eye develop-
ment marker Pax6, tight junction marker zonula occludens 1
(ZO-1), and melanin production marker Tyrosinase
(TYRP1) (Figure 2(g)).
3.3. Both hiPSC-RPE Control and AMD Cells Have
Characteristics Typical of Senescent Cells. SA-β-Gal (senes-
cence-associated beta-galactosidase) activity is present only
in senescent cells and is not found in presenescent, quies-
cent, or immortal cells [30]. Indeed, in a previous study,
we observed that ARPE-19 cell line did not express SA-
β-Gal activity [12]. Here, we observed SA-β-Gal activity
in both hiPSC-RPE Control and AMD cells in 49:8 ± 6:3%
and 75:7 ± 6:5% of cells, respectively (p = 0:0579), suggesting
a senescent cell phenotype of these two kinds of population
(Figures 3(a) and 3(b)).
Morphological and functional changes of mitochondria
occur during aging [31]. In basal condition, both popula-
tions of hiPSC-RPE cells showed the rounded mitochon-
dria (Figure 3(c)) to be classically associated with senescent
cells [32].
3.4. Fe-NTA Exposure Induces More Production of ROS in
hiPSC-RPE AMD Cells. Fe-NTA treatment induced ROS pro-
duction in a dose-dependent manner in both cell lines
(Figure 4(a)). However, ROS production was significantly
higher in hiPSC-RPEAMD cells compared to hiPSC-RPECon-
trol cells from concentration of 10mM (38248 RFU ± 5188
versus 182921 RFU ± 1413, p < 0:05) and above. ROS produc-
tion is linked in part to Fenton reaction and lipofuscin cytotox-
icity [32]. By electronic microscopy analysis, we observed that
Fe-NTA treatment leads to melanolipofuscin production in
both cell lines (Figure 3(c)).
3.5. Changes in Mitochondrial Potential Induced by Fe-NTA
Are Similar in Both iPSC-RPE Cell Lines. Because mitochon-
dria are responsible for most ROS production [31], the
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(a) (b)
(c)
Name Sex
Age 
(years)
Age of diagnostics 
(years)
Clinical 
information
AMD 1 Male 72 59 Bilateral
AMD 2 Male 79 78 Bilateral
AMD 3 Female 76 74 One eye
AMD 4 Male 72 70 Bilateral
AMD 5 Male 75 71 Bilateral
AMD 6 Female 91 89 Bilateral
Control 1 Female 65 – –
Control 2 Male 71 – –
Control 3 Male 81 – –
Control 4 Male 74 – –
Control 5 Female 40 – –
Control 6 Male 46 – –
(d)
Figure 1: Clinical information on healthy individual and patients affected by atrophic AMD included in this study. Fundus examination of (a)
a healthy individual and (b) an atrophic AMD patient. (c) Optical tomography coherence imaging of the patient affected by atrophic AMD.
(d) Donor characteristics and clinical information.
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Figure 2: Characterization of hiPSC and hiPSC-RPE cells. (a) Alkaline phosphatase activity of hiPSC. (b) Quantitative flow cytometry
analysis of both typical embryonic stem cell surface markers TRA1-81 and SSEA-3. (c) Representative immunofluorescence analysis of
pluripotency-specific markers of both stem cells NANOG and OCT-4. Nuclei were stained with DAPI. (d) Typical morphology of hiPSC-
RPE cells. (e) Transmission electron microscopy analysis of RPE cells showing typical morphologic features such microvilli, mitochondria,
and pigmentary granules. (f) Quantitative flow cytometry analysis of stem cell surface marker Lin 28 and of typical RPE cell surface
markers TYRP1 and α-cytokeratin. (g) Representative immunofluorescence analysis of pluripotency-specific markers of typical RPE cell
surface markers BEST-1, PAX6, ZO-1, and TYRP1. Nuclei were stained with DAPI.
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mitochondrial function in both basal and oxidative stress con-
ditions was analyzed. The variation of mitochondrial potential
was measured after Fe-NTA treatment in both cell lines by
FACS using the MitoProbe JC-1 (Figure 4(b)). By quantifica-
tion of the red/green fluorescence ratio, a dose-dependent
decrease of the red fluorescence with Fe-NTA in both cell
lines was measured. For 20mM of Fe-NTA exposure, mito-
chondrial potential of hiPSC-RPE Control and AMD cells
was decreased to 77:1% ± 9:63 and 67:8% ± 9:75, respec-
tively (Figure 4(c)). No differences between hiPSC-RPE
Control and AMD were observed for any dose of Fe-NTA.
3.6. hiPSC-RPE Control and AMD Cells Die by Apoptosis
under Fe-NTA Exposure. Cell death was not observed for
Fe-NTA concentrations inferior to 10mM in hiPSC-RPE
Control cells (Figure 5(a)), while induced cell death of
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Figure 3: (a) SA-β-Gal activity (blue) in both hiPSC-RPE Control and AMD cells. (b) Quantification by manual counting of SA-β-Gal
activity in both hiPSC-RPE Control cells (N = 5) and AMD cells (N = 4). Values are the mean ± SEM. hiPSC-RPE Control: 16 451 cell
count; hiPSC-RPE AMD: 12 829 cell count. Statistical analysis: t-test (two-tailed). (c) Electronic microscopy analysis of hiPSC-RPE
Control and AMD cells in both basal and oxidative stress conditions induced by 10mM Fe-NTA during 24 hours. N: nucleus; m:
mitochondria; ml: melanosome; ly: lysosome; pH: phagosome; MLF: melanolipofuscin. (d) Quantification by manual counting of MLF
production during 10mM FeNTA exposure in hiPSC-RPE Control cells (N = 3) and AMD cells (N = 4).
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Figure 4: Analysis of oxidative stress production and mitochondrial function of hiPSC-RPE during Fe-NTA treatment. (a) Quantification of
DCFH-DA oxidation induced by Fe-NTA treatment during 24 hours in both hiPSC-RPE Control (N = 6) and AMD (N = 6) cells
(triplicate per cell line). (b) Flow cytometry analysis and (c) quantification of mitochondrial membrane potential using MitoProbe
JC-1 staining. Control (N = 6) and AMD (N = 6) (two analyses per cell line). Statistical analysis: two-way ANOVA and post hoc
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Figure 5: Analysis of cell death in both hiPSC-RPE Control and AMD cells during oxidative stress exposure. Quantification by anMTT test of
cell death induced by Fe-NTA treatment during 24 hours in both (a–c) hiPSC-RPE Control (N = 6) and (b, c) AMD (N = 6) cells (triplicate
per cell line). Statistical analysis: one-way ANOVA, post hoc Dunnett and two-way ANOVA, and post hoc Bonferroni. ∗p < 0:05, ∗∗p < 0:01,
and ∗∗∗p < 0:0001. (c) Flow cytometry analysis and (b) quantification of cell death pathway using annexin-V PI staining. Control (N = 4) and
AMD (N = 6) (one analysis per cell line). Comparison of each dose between hiPSC-RPE Control and AMD cells for each dose. Control cells
(N = 6) and AMD cells (N = 6) (triplicate per cell line). Statistical analysis: two-way ANOVA and post hoc Bonferroni. ∗p < 0:05, ∗∗p < 0:01,
and ∗∗∗p < 0:0001.
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hiPSC-RPE AMD cells was observed at Fe-NTA concentra-
tions equal or superior to 5mM (Figure 5(b)). The cellular
viability of hiPSC-RPE AMD cells was significantly lower
than that of hiPSC-RPE Control cells from the concentration
of 5mM (89:3% ± 6 versus 100:5% ± 3:7, p < 0:001) and
above (Figure 5(c)). Furthermore, 50% of cell survival in both
hiPSC-RPE Control and hiPSC-RPE AMD cells was
observed at 16.3 and 14.2mM of Fe-NTA, respectively. By
flow cytometry, we observed that hiPSC-RPE Control and
AMD cells mainly die by apoptosis during Fe-NTA exposure
(43% ± 4:8 and 62:9% ± 4:6 of annexin-V-positive cells,
respectively); less than 10% of cells showed necrotic marker
PI staining (Figures 5(d) and 5(e)).
3.7. Lysosomal Activity of hiPSC-RPE Control and AMD Cells
under Oxidative Stress. No significant difference in global
lysosomal activity was observed in both hiPSC-RPE Control
and AMD cells during basal condition and Fe-NTA expo-
sure (Figures 6(a) and 6(b)). Next, we focus on Cathepsin
D (Cat D), a major lysosomal enzyme that participated in
the retinal homeostasis [33, 34]. Although the amount of
mature Cat D protein was not apparently affected during
Fe-NTA exposure, a dose-dependent increase of the amount
of immature Cat D (pro-Cat D) in both hiPSC-RPE Control
and AMD cells was observed (Figures 6(c) and 6(d)). For an
exposure of 5mM, this increase was significantly higher in
hiPSC-RPE Control cells than in hiPSC-RPE AMD cells
(Figure 6(d), p < 0:05). Cat D maturation is linked to Cat B
activity: the intermediate form of Cat D is cleaved into a
mature enzyme by this cysteine protease [34]. In basal con-
ditions, Cat B activity was 1.3-fold higher in hiPSC-RPE
AMD cells than in Control cells (47910 RFU ðrelative
fluorescence unitÞ ± 4066 versus 63380 RFU ± 6110, p < 0:01)
(Figure 6(e)). In both cell populations, a dose-dependent
decrease of Cat B activity was observed during Fe-NTA treat-
ment to 33% and 26% for 15mM exposure in hiPSC-RPE
Control and AMD cells, respectively (Figure 6(e)). Because
lysosomal activity and Cat B-catalyzed hydrolysis are pH-
dependent [35, 36], we measured lysosomal pH by AO
(acridine orange) staining. As expected, the red/green fluo-
rescence ratio of AO in hiPSC-RPE AMD cells indicated
that the acidity of the vesicles was highest in this cell popu-
lation in basal condition (0:177 ± 0:02 versus 0:255 ± 0:02,
p < 0:01). Fe-NTA treatment leads to a dose-dependent
decrease of red/green fluorescence in both cells (Figure 6(f)).
Oxidative stress exposure leads to a lysosomal membrane per-
meabilization showedby an increase of greenfluorescence com-
pared to the basal condition without Fe-NTA (Figure 6(g)).
4. Discussion
AMD is the most common cause of legal blindness among
persons over 60 years old [3]. In atrophic AMD, RPE cells
are degenerating, secondarily leading to photoreceptor cell
death [37]. The association with chorioretinal atrophy is
unclear, but it is likely that the initial process of the dis-
ease is linked to RPE cells, because other pathological con-
ditions with major choroidal thinning (i.e., degenerative
myopia) lead to RPE atrophy. Since the last decade, many
improvements in cell reprogramming and differentiation
have been made to elucidate the pathological mechanisms
leading to AMD. A deeper understanding of the mecha-
nisms underlying atrophic AMD is necessary to evaluate
promising new therapies.
In this study, 12 hiPSC lines, 6 from healthy individuals
and 6 from patients suffering from atrophic AMD, were
obtained and differentiated into hiPSC-RPE cells. hiPSC-
RPE cells, derived from healthy or AMD patients, had char-
acteristics similar to human RPE cells, with typical expres-
sion of RPE cell markers such as ZO-1, Pax6, Tyrosinase,
and Bestrophin-1 and typical cobblestone epithelial mor-
phology and pigmentation [38].
Classically, oxidative stress is minimized by antioxidant
systems such as glutathione peroxidase or superoxide dis-
mutase [39]. Aging is also associated with an increase of oxi-
dative stress and ROS production [40]. Moreover, in the
retina, the highest metabolic activity is located in the macula,
with the highest ratio of RPE cells by a photoreceptor, leading
to significant production of ROS in RPE cells during aging
[41, 42]. However, with age, RPE cells lose the ability to com-
pensate for ROS production by protective mechanisms,
resulting in oxidative damage [39]. Therapies used to reduce
the progression toward late forms of AMD consequently
consist in diet supplementation with antioxidants [43]. In
our study, we did not observe any differences in basal condi-
tion between hiPSC-RPE Control and AMD cells in terms of
ROS level production. However, Fe-NTA treatment led to
higher production of ROS in hiPSC-RPE AMD cells com-
pared to that in hiPSC-RPE Control cells, suggesting that
hiPSC-RPE AMD cells were more sensitive to the oxidative
stress induced by Fe-NTA treatment than hiPSC-RPE Con-
trol cells. The higher production of ROS in hiPSC-RPE
AMD cells may be explained by differences in damaged orga-
nite morphology leading to oxidative stress. Indeed, elec-
tronic microscopy analysis has shown that RPE cells
obtained from postmortem AMD eyes contained more dam-
aged mitochondria [23] and that the mitochondrial crista
structure was disrupted [44]. Moreover, the overwhelming
majority of cellular ROS has been tracked to the mitochon-
dria [31]. In this context, mitochondrial activity was analyzed
by potential JC-1 staining of the mitochondria membrane.
Fe-NTA treatment led to alteration of the mitochondrial
function without any difference between hiPSC-RPE Control
and AMD cells. Mitochondria functional alteration alone
could thus not explain the higher production of ROS during
Fe-NTA treatment in hiPSC-RPE AMD cells. In fact, while
mitochondrial alteration occurs physiologically with age,
not all elderly people develop AMD [44]. Other mechanisms
may contribute to overproduction of oxidative stress and to
the RPE cell death.
Morphological analysis of postmortem AMD eyes
highlighted distinct disease morphology of other RPE cellular
components such as autophagosome and endoplasmic retic-
ulum, which was wider and more irregular compared to
healthy people [23]. In our electronic microscopy analysis,
we did not observe organite morphological differences
between hiPSC-RPE Control and AMD cells in basal condi-
tion and after Fe-NTA treatment, while the latter led to
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Figure 6: Analysis of hiPSC-RPE lysosomal activity during oxidative stress induced by Fe-NTA treatment. (a) Flow cytometry analysis and (b)
quantification of global lysosomal activity in both hiPSC-RPE Control (N = 5) and AMD (N = 6) cells (one analysis per cell line). Statistical
analysis: two-way ANOVA and post hoc Bonferroni. (c) Western blot analysis of pro-Cat D and mature Cat D and (d) western blot
quantification in both hiPSC-RPE Control cells (N = 6) and AMD cells (N = 6) (one analysis per cell line). Statistical analysis: two-way
ANOVA and post hoc Fisher LSD. Comparison of each dose between hiPSC-RPE Control and AMD cells (∗). ∗p < 0:05. (e) Analysis of
hiPSC-RPE Control cells (N = 6) and AMD cells (N = 6) cell Cat B activity (four analyses per cell line). Statistical analysis: two-way ANOVA
and post hoc Bonferroni. Comparison of each dose between hiPSC-RPE Control and AMD cells (∗). ∗p < 0:05 and ∗∗p < 0:01. (f)
Comparison of the ratio of the dimer or oligomer to the monomer of acridine orange in hiPSC-RPE Control (N = 6) and AMD (N = 5) cells
(triplicate per cell line). ∗Comparison of each dose between hiPSC-RPE Control and AMD cells for each dose. $Comparison of each dose
between basal condition for hiPSC-RPE Control and AMD cells. Statistical analysis: two-way ANOVA and post hoc Bonferroni. ∗,$p < 0:05,
∗∗,$$p < 0:01, and ∗∗∗,$$$p < 0:0001. (g) Lysosomal membrane stability was measured by AO staining under a fluorescence microscopy.
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lipofuscin production in both cell lines. Endoplasmic retic-
ulum stress could induce VEGF secretion, which could be
involved in the lysosomal accumulation of lipofuscin
within RPE cells [45]. The accumulation of lipofuscin
[15] in senescent RPE cells is often considered a hallmark
of aging [46]. As previously described [47], aging is the
major risk factor of AMD development. Morphological
changes of RPE cells related to aging include loss of mel-
anin granules, increased density of residual body, and
accumulation of lipofuscin [16]. Here, we have demon-
strated that both hiPSC-RPE Control and AMD cells
derived from aged individuals express a senescent profile
by the expression of SA-β-Gal activity, a classical aging
marker [30]. Mitochondrial morphology modifications
related to senescence confirmed the aging phenotype of
hiPSC-RPE Control and AMD cells achieved in this study.
The increase of β-Gal activity with replicative senescence
and aging is linked to increased lysosomal activity [48].
Indeed, β-Gal activity may be the reflection of lysosomal
activity [46]. Lysosomal activity is a process involved in
the degradation of photoreceptor outer segments in RPE
cells [49] and in replacement of damaged mitochondria
by mitophagy [50]. With aging, degradation and/or repa-
ration processes could be less efficient and may lead to
an accumulation of damaged components such as mito-
chondria, as previously shown [23]. Furthermore, the
accumulation of iron in AMD is associated with decreased
lysosomal activity [22, 51]. One of mechanistic AMD
hypotheses is based on lipid peroxidation related to
impairment of lysosomal function. This process may con-
tribute to RPE cell dysfunction via intracellular processes
that directly reduced the lysosomal activity [22]. In our
study, we did not observed any difference in global lyso-
somal activity between hiPSC-RPE Control and AMD
cells, neither in basal nor in oxidative stress condition.
However, we observed that Cat B activity was higher in
hiPSC-RPE AMD cells and probably linked to a more
acidic lysosomal environment. Indeed, Cat B cleaved the
N-terminal segment of Cat D leading to its activation at
low pH [52]. In our study, we also observed that, during
Fe-NTA exposure, Cat B activity is inhibited in the two
populations. This result is correlated with the dose-
dependent increase of the immature form during oxidative
stress condition, which was observed in both populations,
while appearing more rapidly in hiPSC-RPE Control cells.
The lower Cat B activity in hiPSC-RPE Control cells could
explain that more pro-Cat D was found in this population
compared to hiPSC-RPE AMD cells. As previously
described with an immortalized cell model of RPE,
ARPE-19, iron accumulation increases the immature form
of Cat D, without any change in the mature form [16].
Our study also confirmed these results in hiPSC-RPE Con-
trol and AMD cells. Any abnormalities in this enzyme sys-
tem may have pathological consequences. Indeed, the
presence of Cat D has been shown to be associated with
accumulation of undigested (photoreceptor outer segment)
derived debris, which could contribute to drusen forma-
tion. Chen et al. [16] hypothesized that iron overload in
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Figure 7: Graphic summary of typical disease phenotype of hiPSC-RPE AMD cells compared to hiPSC-RPE Control cells in the
production of reactive oxygen species, cellular viability, and lysosomal function in response to oxidative stress induced by intracellular
accumulation of iron.
12 Oxidative Medicine and Cellular Longevity
ARPE-19 inhibited the conversion process of pro-Cat D
into Cat D.
In our study, we compared hiPSC-RPE cells derived from
somatic cells of healthy persons to those derived from
patients affected by atrophic AMD. Taken together, our
results demonstrate that hiPSC-RPE cells from patients
affected by atrophic AMD had a specific phenotype com-
pared to hiPSC-RPE Control cells. Recently, Golestaneh
et al. [4] obtained the same typical phenotype with hiPSC-
RPE cells derived from postmortem RPE cells as the control
population in response to oxidative stress induced by H2O2,
which is currently used in vitro to rapidly induce oxidative
stress. In our study, treatment with iron was preferred as a
mean of inducing iron accumulation as it mimics the proox-
idant microenvironment observed in AMD and during the
aging process. Iron is a natural element that accumulates
with normal aging [16]. Additionally, it has been observed
that concentration of iron was greater in the macular area
and RPE cells in individuals affected by atrophic AMD
[21]. Specific iron accumulation has been associated in RPE
cells and photoreceptor degeneration in other retinal injuries
[20]. Oxidative stress induced by iron is responsible for spe-
cific activation pathways such as ferroptosis [53]. Taken all
together, these different studies suggested that iron is proba-
bly a more reliable tool than H2O2 (i) to induce oxidative
stress in vitro and (ii) to model the oxidative stress mecha-
nisms that occur in vivo in the RPE cells of AMD patients.
We demonstrated that hiPSC-RPE cells derived from
patients affected by atrophic AMD expressed a specific dis-
ease phenotype compared to iPSC-RPE cells derived from
healthy individuals as illustrated in Figure 7. Indeed,
hiPSC-RPE AMD cells were more sensitive to oxidative stress
and produced more ROS under a prooxidant environment.
They also show dysregulation of lysosomal activities in basal
condition and during oxidative stress exposure. In our study,
we demonstrate that, despite reprogramming and differenti-
ation process, cells derived from AMD patients exhibit path-
ological mechanisms leading to a distinct phenotype. These
results support the evidence that (i) lysosomal activity of
RPE cells plays a central role in the pathogenesis of AMD
and (ii) hiPSC-RPE cells derived from erythroblasts of
AMD patients express a disease phenotype and (iii) could
be a useful tool to study pathological mechanisms leading
to the development of AMD or to evaluate potential thera-
peutic molecules.
5. Conclusion
In this study, hiPSC-RPE cell lines derived from atrophic
AMD patients were compared to hiPSC-RPE cell lines
derived from healthy people. We observed a critical differ-
ence in terms of production of reactive oxygen species, cellu-
lar viability, and lysosomal function in response to oxidative
stress induced by intracellular accumulation of iron. These
findings demonstrate that (i) hiPSC-RPE AMD cells have a
typical disease phenotype compared to hiPSC-RPE Control
cells and that (ii) dysfunction of RPE cell lysosomal activity
is involved in pathological mechanisms of AMD.
Data Availability
The datasets generated and/or analyzed during the current
study are available from the corresponding author on reason-
able request.
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
This work was funded by grants from the Novartis, the CHU
Poitiers, the Fond Alienor, the association DMLA, the finan-
cial participation of the European Union’s FEDER, and the
Region of Nouvelle Aquitaine. The authors would like to
thank Jeffrey Arsham for having reread and corrected our
original English language manuscript, Adriana Delwail for
her help during cytometry experiments, Anaïs Balbous for
rereading the manuscript, and Pr Jack Flacon and Pr Alicia
Torriglia for their MET analysis.
References
[1] K. Sharma, N. K. Sharma, and A. Anand, “Why AMD is a
disease of ageing and not of development: mechanisms and
insights,” Frontiers in Aging Neuroscience, vol. 6, p. 151,
2014.
[2] P. De Jong, “Age-related macular degeneration,” New England
Journal of Medicine, vol. 355, no. 14, pp. 1474–1485, 2006.
[3] K. M. Gehrs, D. H. Anderson, L. V. Johnson, and G. S.
Hageman, “Age-related macular degeneration—emerging
pathogenetic and therapeutic concepts,” Annals of Medicine,
vol. 38, no. 7, pp. 450–471, 2006.
[4] N. Golestaneh, Y. Chu, S. K. Cheng, H. Cao, E. Poliakov, and
D. M. Berinstein, “Repressed SIRT1/PGC-1α pathway and
mitochondrial disintegration in iPSC-derived RPE disease
model of age-related macular degeneration,” Journal of Trans-
lational Medicine, vol. 14, no. 1, p. 344, 2016.
[5] V. Y. Ng and A. B. Choo, “iPS and ES cells: do both roads lead
to Rome,” Open Stem Cell Journal, vol. 2, pp. 8–17, 2010.
[6] S. Reichman, A. Terray, A. Slembrouck et al., “From confluent
human iPS cells to self-forming neural retina and retinal pig-
mented epithelium,” Proceedings of the National Academy of
Sciences, vol. 111, no. 23, pp. 8518–8523, 2014.
[7] D. E. Buchholz, B. O. Pennington, R. H. Croze, C. R. Hinman,
P. J. Coffey, and D. O. Clegg, “Rapid and efficient directed
differentiation of human pluripotent stem cells into retinal
pigmented epithelium,” Stem Cells Translational Medicine,
vol. 2, no. 5, pp. 384–393, 2013.
[8] J. Maruotti, K. Wahlin, D. Gorrell, I. Bhutto, G. Lutty, and D. J.
Zack, “A simple and scalable process for the differentiation of
retinal pigment epithelium from human pluripotent stem
cells,” Stem Cells Translational Medicine, vol. 2, no. 5,
pp. 341–354, 2013.
[9] M. Parvini, L. Satarian, K. Parivar et al., “Human pluripotent
stem cell-derived retinal pigmented epithelium in retinal treat-
ment: from bench to bedside,”Molecular Neurobiology, vol. 50,
no. 2, pp. 597–612, 2014.
[10] Z. Ablonczy, M. Dahrouj, P. H. Tang et al., “Human retinal
pigment epithelium cells as functional models for the RPE
13Oxidative Medicine and Cellular Longevity
in vivo,” Investigative Ophthalmology & Visual Science, vol. 52,
no. 12, pp. 8614–8620, 2011.
[11] H. Cai and L. V. Del Priore, “Gene expression profile of cul-
tured adult compared to immortalized human RPE,” Molecu-
lar Vision, vol. 12, pp. 1–14, 2006.
[12] A. Voisin, C. Monville, A. Plancheron, A. Balbous,
A. Gaillard, and N. Leveziel, “hRPE cells derived from
induced pluripotent stem cells are more sensitive to oxida-
tive stress than ARPE-19 cells,” Experimental Eye Research,
vol. 177, pp. 76–86, 2018.
[13] O. Strauss, “The retinal pigment epithelium in visual func-
tion,” Physiological Reviews, vol. 85, no. 3, pp. 845–881, 2005.
[14] V. L. Bonilha, “Age and disease-related structural changes in
the retinal pigment epithelium,” Clinical Ophthalmology,
vol. 2, no. 2, pp. 413–424, 2008.
[15] T. Ach, E. Tolstik, J. D. Messinger, A. V. Zarubina,
R. Heintzmann, and C. A. Curcio, “Lipofuscin redistribution
and loss accompanied by cytoskeletal stress in retinal pigment
epithelium of eyes with age-related macular degeneration,”
Investigative Ophthalmology & Visual Science, vol. 56, no. 5,
pp. 3242–3252, 2015.
[16] H. Chen, T. J. Lukas, N. Du, G. Suyeoka, and A. H. Neufeld,
“Dysfunction of the retinal pigment epithelium with age:
increased Iron decreases phagocytosis and lysosomal activity,”
Investigative Opthalmology & Visual Science, vol. 50, no. 4,
p. 1895, 2009.
[17] M. R. Terluk, R. J. Kapphahn, L. M. Soukup et al., “Investigat-
ing mitochondria as a target for treating age-related macular
degeneration,” Journal of Neuroscience, vol. 35, no. 18,
pp. 7304–7311, 2015.
[18] D. M. Rabin, R. L. Rabin, T. A. Blenkinsop, S. Temple, and J. H.
Stern, “Chronic oxidative stress upregulates drusen-related
protein expression in adult human RPE stem cell-derived
RPE cells: a novel culture model for dry AMD,” Aging, vol. 5,
no. 1, pp. 51–66, 2013.
[19] D. Song, L. N. Kanu, Y. Li et al., “AMD-like retinopathy asso-
ciated with intravenous iron,” Experimental Eye Research,
vol. 151, pp. 122–133, 2016.
[20] X. He, P. Hahn, J. Iacovelli et al., “Iron homeostasis and toxic-
ity in retinal degeneration,” Progress in Retinal and Eye
Research, vol. 26, no. 6, pp. 649–673, 2007.
[21] T. Dentchev, P. Hahn, and J. L. Dunaief, “Strong labeling for
iron and the iron-handling proteins ferritin and ferroportin
in the photoreceptor layer in age-related macular degenera-
tion,” Archives of Ophthalmology, vol. 123, no. 12, pp. 1745-
1746, 2005.
[22] M. Karlsson and T. Kurz, “Attenuation of iron-binding pro-
teins in ARPE-19 cells reduces their resistance to oxidative
stress,” Acta Ophthalmologica, vol. 94, no. 6, pp. 556–564,
2016.
[23] N. Golestaneh, Y. Chu, Y.-Y. Xiao, G. L. Stoleru, and A. C.
Theos, “Dysfunctional autophagy in RPE, a contributing factor
in age-related macular degeneration,” Cell Death & Disease,
vol. 8, no. 1, article e2537, 2017.
[24] J. Yang, Y. Li, L. Chan et al., “Validation of genome-wide asso-
ciation study (GWAS)-identified disease risk alleles with
patient-specific stem cell lines,” Human Molecular Genetics,
vol. 23, no. 13, pp. 3445–3455, 2014.
[25] A. Rosenkranz, S. Schmaldienst, K. Stuhlmeier, W. Chen,
W. Knapp, and G. Zlabinger, “A microplate assay for the
detection of oxidative products using 2′,7′-dichlorofluores-
cin-diacetate,” Journal of Immunological Methods, vol. 156,
no. 1, pp. 39–45, 1992.
[26] T. Mosmann, “Rapid colorimetric assay for cellular growth
and survival: application to proliferation and cytotoxicity
assays,” Journal of Immunological Methods, vol. 65, no. 1-2,
pp. 55–63, 1983.
[27] S. Taghiloo, E. Allahmoradi, M. Tehrani et al., “Frequency and
functional characterization of Exhausted CD8 + T-cells in
chronic lymphocytic leukemia,” European Journal of Haema-
tology, vol. 98, no. 6, pp. 622–631, 2017.
[28] B. Xiao, X. Deng, W. Zhou, and E.-K. Tan, “Flow cytometry-
based assessment of mitophagy using MitoTracker,” Frontiers
in Cellular Neuroscience, vol. 10, p. 76, 2016.
[29] L. Liu, N. Zhang, Y. Dou et al., “Lysosomal dysfunction and
autophagy blockade contribute to IMB-6G-induced apoptosis
in pancreatic cancer cells,” Scientific Reports, vol. 7, no. 1, arti-
cle 41862, 2017.
[30] G. P. Dimri, X. Lee, G. Basile et al., “A biomarker that identifies
senescent human cells in culture and in aging skin in vivo,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 92, no. 20, pp. 9363–9367, 1995.
[31] R. S. Balaban, S. Nemoto, and T. Finkel, “Mitochondria, oxi-
dants, and aging,” Cell, vol. 120, no. 4, pp. 483–495, 2005.
[32] A. Höhn and T. Grune, “Lipofuscin: formation, effects and role
of macroautophagy,” Redox Biology, vol. 1, pp. 140–144, 2013.
[33] P. Benes, V. Vetvicka, and M. Fusek, “Cathepsin D—many
functions of one aspartic protease,” Critical Reviews in Oncolo-
gy/Hematology, vol. 68, no. 1, pp. 12–28, 2008.
[34] V. Laurent-Matha, D. Derocq, C. Prébois, N. Katunuma, and
E. Liaudet-Coopman, “Processing of human cathepsin D is
independent of its catalytic function and auto-activation:
involvement of cathepsins L and B,” The Journal of Biochemis-
try, vol. 139, no. 3, pp. 363–371, 2006.
[35] A. Kawai, H. Uchiyama, S. Takano, N. Nakamura, and
S. Ohkuma, “Autophagosome-lysosome fusion depends on
the pH in acidic compartments in CHO cells,” Autophagy,
vol. 3, no. 2, pp. 154–157, 2007.
[36] H. E. Khouri, C. Plouffe, S. Hasnain, T. Hirama, A. C. Storer,
and R. Ménard, “A model to explain the pH-dependent speci-
ficity of cathepsin B-catalysed hydrolyses,” Biochemical Jour-
nal, vol. 275, Part 3, pp. 751–757, 1991.
[37] J. S. Saini, B. Corneo, J. D. Miller et al., “Nicotinamide Amelio-
rates Disease Phenotypes in a Human iPSC Model of Age-
Related Macular Degeneration,” Cell Stem Cell, vol. 20, no. 5,
pp. 635–647.e7, 2017.
[38] W. Samuel, C. Jaworski, O. A. Postnikova et al., “Appropri-
ately differentiated ARPE-19 cells regain phenotype and gene
expression profiles similar to those of native RPE cells,”Molec-
ular Vision, vol. 23, p. 60, 2017.
[39] S. G. Jarrett and M. E. Boulton, “Consequences of oxidative
stress in age-related macular degeneration,”Molecular Aspects
of Medicine, vol. 33, no. 4, pp. 399–417, 2012.
[40] D. Praticò, “Lipid peroxidation and the aging process,” Science
of Aging Knowledge Environment, vol. 2002, no. 50, p. 5re,
2002.
[41] S. Khandhadia and A. Lotery, “Oxidation and age-related mac-
ular degeneration: insights from molecular biology,” Expert
Reviews in Molecular Medicine, vol. 12, article e34, 2010.
[42] T. Y. Garcia, M. Gutierrez, J. Reynolds, and D. A. Lamba,
“Modeling the dynamic AMD-associated chronic oxidative
stress changes in human ESC and iPSC-derived RPE cells,”
14 Oxidative Medicine and Cellular Longevity
Investigative Opthalmology & Visual Science, vol. 56, no. 12,
p. 7480, 2015.
[43] D. Smailhodzic, F. van Asten, A. M. Blom et al., “Zinc supple-
mentation inhibits complement activation in age-related mac-
ular degeneration,” PLoS One, vol. 9, no. 11, article e112682,
2014.
[44] E. Lefevere, A. K. Toft-Kehler, R. Vohra, M. Kolko, L. Moons,
and I. Van Hove, “Mitochondrial dysfunction underlying
outer retinal diseases,” Mitochondrion, vol. 36, pp. 66–76,
2017.
[45] A. Salminen, A. Kauppinen, J. M. Hyttinen, E. Toropainen,
and K. Kaarniranta, “Endoplasmic reticulum stress in age-
related macular degeneration: trigger for neovascularization,”
Molecular Medicine, vol. 16, no. 11-12, pp. 535–542, 2010.
[46] T. Kurz, A. Terman, and U. T. Brunk, “Autophagy, ageing and
apoptosis: the role of oxidative stress and lysosomal iron,”
Archives of Biochemistry and Biophysics, vol. 462, no. 2,
pp. 220–230, 2007.
[47] C. Bowes Rickman, S. Farsiu, C. A. Toth, and M. Klingeborn,
“Dry age-related macular degeneration: mechanisms, thera-
peutic targets, and imaging,” Investigative Opthalmology &
Visual Science, vol. 54, no. 14, pp. ORSF68–ORSF80, 2013.
[48] B. Y. Lee, J. A. Han, J. S. Im et al., “Senescence-associated beta-
galactosidase is lysosomal beta-galactosidase,” Aging Cell,
vol. 5, no. 2, pp. 187–195, 2006.
[49] B. M. Kevany and K. Palczewski, “Phagocytosis of retinal
rod and cone photoreceptors,” Physiology, vol. 25, no. 1,
pp. 8–15, 2010.
[50] B. Bingol and M. Sheng, “Mechanisms of mitophagy: PINK1,
Parkin, USP30 and beyond,” Free Radical Biology & Medicine,
vol. 100, pp. 210–222, 2016.
[51] T. U. Krohne, E. Kaemmerer, F. G. Holz, and J. Kopitz, “Lipid
peroxidation products reduce lysosomal protease activities in
human retinal pigment epithelial cells via two different mech-
anisms of action,” Experimental Eye Research, vol. 90, no. 2,
pp. 261–266, 2010.
[52] Y. Tanaka, G. Suzuki, T. Matsuwaki et al., “Progranulin regu-
lates lysosomal function and biogenesis through acidification
of lysosomes,” Human Molecular Genetics, vol. 26, no. 5,
pp. 969–988, 2017.
[53] S. J. Dixon, K. M. Lemberg, M. R. Lamprecht et al., “Ferropto-
sis: an iron-dependent form of nonapoptotic cell death,” Cell,
vol. 149, no. 5, pp. 1060–1072, 2012.
15Oxidative Medicine and Cellular Longevity
